Coral Laboratories Quarterly Results for Trading Insights
CORALAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹24 Cr
QMarch 2025
Coral Laboratories Quarterly Results Key Highlights
- Revenue of ₹124 Cr in March 2025 (+0.0% vs March 2025, +37.8% vs March 2024)
- Net Profit of ₹24 Cr in March 2025 (+0.0% vs March 2025, +50.0% vs March 2024)
- EBITDA of ₹35 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 23.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹67.61 in March 2025 (+0.0% vs March 2025)
Coral Laboratories Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 99 | 124 | 90 | 85 | 80 | -20.2% | - |
| Net Profit (₹ Cr) | 17 | 24 | 16 | 6 | 9 | - | - |
| EBITDA (₹ Cr) | 25 | 35 | 23 | 11 | 13 | - | - |
| EPS (₹) | 48.60 | 67.61 | 44.19 | 18.04 | 25.32 | - | - |
| Operating Margin (%) | 18.0% | 23.0% | 19.0% | 5.0% | 11.0% | - | - |
Coral Laboratories Share Price Trend Around Quarterly Results
Visualize Coral Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Coral Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Coral Laboratories
Additional stock information and data for CORALAB
Revenue Trend (₹ Cr)
March 2023
85
March 2024
90
March 2025
124
2026
99
Net Profit Trend (₹ Cr)
March 2023
6
March 2024
16
March 2025
24
2026
17
Operating Margin Trend (%)
March 2023
5.0%
March 2024
19.0%
March 2025
23.0%
2026
18.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Coral Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹391,547.47 Cr | 1702.1 | 14,875 | 3,125 | +10.8% | - | 21.0% | 130.9 |
|
Divis Laboratories
Sept 2025 |
₹160,887.23 Cr | 6209.0 | 2,860 | 689 | +7.1% | - | 24.1% | 239.1 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,071.99 Cr | 4045.6 | 3,219 | 591 | +11.3% | - | 18.4% | 230.6 |
|
Cipla
Sept 2025 |
₹110,697.00 Cr | 1322.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.1 |
|
Dr Reddys Laborator…
Sept 2025 |
₹103,126.93 Cr | 1235.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.4 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores